qynapse.com rapport :   Visitez le site

Données techniques du qynapse.com

Geo IP vous fournit comme la latitude, la longitude et l'ISP (Internet Service Provider) etc. informations. Notre service GeoIP a trouvé l'hôte qynapse.com.Actuellement, hébergé dans France et son fournisseur de services est OVH SAS .

the related websites

domaine	Titre
qynapse.com	qynapse - quantitative imaging and beyond
vitecimagingdistribution.fr	vitec imaging distribution
medicalimagingstore.com	medical imaging store
faro.com	faro | 3d measurement, imaging & realization technology
bogenimaging.fr	bogen imaging - système professionnels de news brutes
makhymo.it	makhymo s.r.l - office imaging technology - asti - home
digitalsurf.com	digital surf » surface imaging, analysis and metrology software
altix.fr	altix: printed circuit board machines & uv imaging system
studiobackdrops.com	studiobackdrops.com | imaging ahead | studiobackdrops.com

societe.com challenges.fr franceisai.com synapse-entreprises.com fr.wikipedia.org 

Analyse d'en-tête HTTP

Les informations d'en-tête HTTP font partie du protocole HTTP que le navigateur d'un utilisateur envoie à appelé Apache contenant les détails de ce que le navigateur veut et acceptera de nouveau du serveur Web.

DNS

HtmlToText

what we do technology clinical trials clinical routine about us contact careers fr / en menu what we do technology clinical trials clinical routine about us contact careers fr / en optimal measures. optimized therapies. learn more what we do leveraging medical images to support personalized therapies. quantitative imaging plays a key role for personalized medicine. it enables more accurate diagnosis and drug efficacy measurement, while providing the potential to predict clinical evolution and drug efficacy for disease-changing therapies. qynapse innovates in this area by delivering a unique technology for biomarkers analysis and monitoring. technology qyscore ® is a cloud-based software for the automated extraction, quantification and comparison to normative dataset of imaging markers of central nervous system (cns) diseases. imaging features : brain white matter lesion load grey and white matter volumes hippocampal volume amygdala volume basal ganglia volume thalamic volume cerebellar volume spinal cord volume clinical applications : multiple sclerosis alzheimer's disease parkinson's disease epilepsy stroke bipolar disorder post-traumatic stress disorder qyscore ® is fully automated, providing reliable results in a few minutes, either through an intuitive user interface or a clinical report. individual analysis is presented in comparison with a normative dataset of healthy subjects, to support decision-making in both clinical trials and clinical routine. global and local atrophies lesion load clinical trials qynapse delivers precise, fast and reliable data analyses, leading to the best therapies assessments through the most relevant imaging endpoints and the most accurate selection of patients, for more targeted and successful clinical trials. our team provides the following services for effective clinical trials planning and management: ultimately, the implementation of standardized imaging protocols along with qyscore ® automated quantification reduces inter and intra-rater variability inherent to the visual analysis of mri data. clinical routine clinical benefit in the clinical routine, qyscore ® provides automated, reliable and reproducible measurements of brain structures from mr image to support: differential diagnosis measurement of clinical progression measurement of drug efficacy monitoring of drug adverse effects results are presented in comparison to normative data for a given time point and across time for the same patient. a cloud-based platform qyscore ® can be fully integrated into routine clinical practice through leading ris/pacs systems, and can be operated with any mri scan from 1.5t and 3t scanners. about us qynapse is a medical technology company, spin-off of the renowned cati consortium of neuroimaging research laboratories. headquartered in paris, qynapse provides a cloud-based solution for pharmaceutical companies and healthcare providers to support the diagnosis, prognosis and drug efficacy measurement for central nervous system diseases (such as dementia, multiple sclerosis, parkinson’s and ischemic stroke). qynapse is iso 13485:2016-certified. management team olivier courrèges ceo linkedin clarisse longo dos santos, phd head of clinical development linkedin jean-baptiste martini head of software development linkedin cécilia damon, phd data science leader linkedin partners we have developed strategic partnerships to deliver state of the art technology and services for imaging biomarkers analysis and monitoring. our key technology partners and sponsors include: technology: accelerators: grants and awards: contact twitter linkedin contact[@]qynapse.com careers optimal measures. optimized therapies. our mission at qynapse is to transform the development and clinical management of innovative therapies for central nervous system diseases. leveraging cutting-edge image analysis and machine learning technology with unmatched clinical expertise, we develop and commercialize medical devices software that help diagnose, predict clinical evolution and measure drug efficacy in an unprecedented way. we are looking for exceptional talents who are ready to make a difference. here are our current job openings: business development vp don't hesitate to contact us at careers[@]qynapse.com if our current open positions do not match your profile. © 2017 qynapse sas rcs paris 815 093 356

Analyse PopURL pour qynapse.com

http://www.qynapse.com/pdf/20180301_cdi_business_development_vp.pdf
http://www.qynapse.com/#careers
http://www.qynapse.com/index.html
http://www.qynapse.com/#about-us
http://www.qynapse.com/#software
http://www.qynapse.com/#menu
http://www.qynapse.com/#clinical-routine
http://www.qynapse.com/#contact
http://www.qynapse.com/#clinical-trials
http://www.qynapse.com/#technology
http://www.qynapse.com/index_fr.html
cnrs.fr
enseignementsup-recherche.gouv.fr
bpifrance.fr
english.inserm.fr
upmc.fr
paris.fr
i2bm.cea.fr
inria.fr
cea.fr

Informations Whois

Whois est un protocole qui permet d'accéder aux informations d'enregistrement.Vous pouvez atteindre quand le site Web a été enregistré, quand il va expirer, quelles sont les coordonnées du site avec les informations suivantes. En un mot, il comprend ces informations;

Domain Name: QYNAPSE.COM
Registry Domain ID: 1904659908_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.ovh.com
Registrar URL: http://www.ovh.com
Updated Date: 2016-02-01T16:52:31Z
Creation Date: 2015-02-22T01:21:13Z
Registry Expiry Date: 2020-02-22T01:21:13Z
Registrar: OVH
Registrar IANA ID: 433
Registrar Abuse Contact Email:
Registrar Abuse Contact Phone:
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: DNS200.ANYCAST.ME
Name Server: NS200.ANYCAST.ME
DNSSEC: unsigned
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of whois database: 2018-06-01T22:54:40Z <<<

For more information on Whois status codes, please visit https://icann.org/epp

NOTICE: The expiration date displayed in this record is the date the
registrar's sponsorship of the domain name registration in the registry is
currently set to expire. This date does not necessarily reflect the expiration
date of the domain name registrant's agreement with the sponsoring
registrar. Users may consult the sponsoring registrar's Whois database to
view the registrar's reported date of expiration for this registration.

TERMS OF USE: You are not authorized to access or query our Whois
database through the use of electronic processes that are high-volume and
automated except as reasonably necessary to register domain names or
modify existing registrations; the Data in VeriSign Global Registry
Services' ("VeriSign") Whois database is provided by VeriSign for
information purposes only, and to assist persons in obtaining information
about or related to a domain name registration record. VeriSign does not
guarantee its accuracy. By submitting a Whois query, you agree to abide
by the following terms of use: You agree that you may use this Data only
for lawful purposes and that under no circumstances will you use this Data
to: (1) allow, enable, or otherwise support the transmission of mass
unsolicited, commercial advertising or solicitations via e-mail, telephone,
or facsimile; or (2) enable high volume, automated, electronic processes
that apply to VeriSign (or its computer systems). The compilation,
repackaging, dissemination or other use of this Data is expressly
prohibited without the prior written consent of VeriSign. You agree not to
use electronic processes that are automated and high-volume to access or
query the Whois database except as reasonably necessary to register
domain names or modify existing registrations. VeriSign reserves the right
to restrict your access to the Whois database in its sole discretion to ensure
operational stability. VeriSign may restrict or terminate your access to the
Whois database for failure to abide by these terms of use. VeriSign
reserves the right to modify these terms at any time.

The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.

  REGISTRAR OVH

SERVERS

  SERVER com.whois-servers.net

  ARGS domain =qynapse.com

  PORT 43

  TYPE domain
RegrInfo
DOMAIN

  NAME qynapse.com

  CHANGED 2016-02-01

  CREATED 2015-02-22

STATUS
clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
clientTransferProhibited https://icann.org/epp#clientTransferProhibited

NSERVER

  DNS200.ANYCAST.ME 46.105.206.200

  NS200.ANYCAST.ME 46.105.207.200

  REGISTERED yes

Erreurs

La liste suivante vous montre les fautes d'orthographe possibles des internautes pour le site Web recherché.